Candesant Biomedical Receives FDA Clearance of Brella™¹, the First and Only 3-Minute SweatControl Patch™, to Significantly Reduce Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)
/PRNewswire/ -- Candesant Biomedical ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive...
New Orleans United States Suzanne Haber Dee Anna Glaser Candesant Biomedical Inc Consumer Survey On Cosmetic Dermatologic Procedures
Source: prnewswire.com